Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Alcohol Clin Exp Res. 2010 Dec 1;35(2):284–294. doi: 10.1111/j.1530-0277.2010.01344.x

Table 1.

Demographics and clinical characteristics of subjects with alcohol use disorders (AUDs) and control subjects for test and confirmation cohorts.

Test Cohort Confirmation Cohort
AUD Subjects, n=7 Control Subjects, n=7 AUD Subjects, n=7 Control Subjects, n=7
Age, mean 44 ± 6 37 ± 11 42 ± 9 38 ± 12
Gender, no. women/men 0/7 0/7 5/2 5/2
Tobacco use, % 5/7 (71%) 5/7 (71%) 4/7 (57%) 4/7 (57%)
AUDIT score* 27 ± 9 <1 26 ± 7 <1
Days/week consuming alcohol 5 ± 2 -- 6 ± 1 --
Years consuming alcohol 30 ± 6 -- 25 ± 6
FEV1, % predicted 94 ± 9 85 ± 7 93 ± 11 90 ± 12
FVC, % predicted 97 ± 9 93 ± 7 96 ± 15 93 ± 16
BAL cell count per mL (in millions) 21 ± 12 25 ± 21 19 ± 10 24 ± 24
Monos/macrophages, % 91 ± 3 93 ± 4 91±2 96 ± 2
Lymphocytes, % 6 ± 3 6 ± 4 7±2 3 ± 1
Neutrophils, % 3 ± 2 2 ± 1 2±1 2 ± 1
*

The Alcohol Use Disorders Identification Test (AUDIT) score is calculated from a validated 10 question survey to identify current alcohol use that has been utilized in a variety of clinical settings. AUD was defined as an AUDIT score of ≥8 in men, and ≥5 in women. FEV1=forced expiratory volume in the first second of expiration; FVC=forced vital capacity; BAL=bronchoalveolar lavage.